NCT03141125View on ClinicalTrials.gov

The Effect of Ethanol Extract Physalis Angulata Linn. in Scleroderma Patients With Standard Therapy

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Scleroderma
Interventions
OTHER

Physalis angulata ethanol extract

Ethanol extract of physalis angulate Linn with dosage of 3x250 mg/day given orally for 3 months

OTHER

Placebo

No active component at the same dosage of 3x250 mg/day given orally for 3 months

Trial Locations (2)

10430

Ciptomangunkusumo Hospital, Jakarta

40161

Hasan Sadikin Hospital, Bandung

All Listed Sponsors
collaborator

Netherlands: Ministry of Health, Welfare and Sports

OTHER_GOV

lead

Indonesia University

OTHER

NCT03141125 - The Effect of Ethanol Extract Physalis Angulata Linn. in Scleroderma Patients With Standard Therapy | Biotech Hunter | Biotech Hunter